Suppr超能文献

药品生殖和发育毒性试验国际指南提案。

Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.

作者信息

Lumley C E

机构信息

Centre for Medicines Research, Carshalton, Surrey, UK.

出版信息

Adverse Drug React Toxicol Rev. 1991 Autumn;10(3):143-53.

PMID:1747441
Abstract
  1. A Workshop was organized by the Centre for Medicines Research in London, 13th-15th May 1991 to discuss the current situation concerning tests for reproductive and developmental toxicity required for new drug development, and whether a unified series of guidelines could be developed which would satisfy Regulatory Authorities and Scientists worldwide. 2. The international group of experts invited to participate in this meeting reached a consensus regarding the desirability of developing new and flexible guidelines. An approach was proposed based on the state of the art of scientific knowledge in the field of reproductive and developmental toxicology coupled with the minimum use of experimental animals, and taking into consideration the European proposal for a new guideline which has been open for discussion since 1989. 3. Although time did not permit detailed discussion of all study designs, several which are considered to provide acceptable tests for reproductive and developmental toxicity of new therapeutic candidates have been proposed for further discussion. These include the possibility of considerable reduction in duration and size of studies, and numbers of animals used where there is an indication that a low hazard potential exists. 4. Whichever of the combinations are ultimately used in the premarketing assessment, it is most important that the investigators justify in detail the rationale underlying the choice of studies undertaken. This should take into account the specific properties of the drug molecule and its proposed clinical use. 5. This paper reflects the discussions which took place at the Workshop and its publication has been agreed to by the participants. It is intended that it could be used as the basis for discussions of a harmonized approach to reproductive and developmental toxicity testing of pharmaceuticals. As such, it will be made available to regulatory agencies, trade associations and other appropriate groups for their consideration and acceptance, modification or scientific augmentation.
摘要
  1. 1991年5月13日至15日,伦敦药物研究中心组织了一次研讨会,以讨论新药开发所需的生殖和发育毒性测试的现状,以及是否可以制定一套统一的指南,以满足全球监管机构和科学家的需求。2. 受邀参加此次会议的国际专家小组就制定新的灵活指南的可取性达成了共识。提出了一种基于生殖和发育毒理学领域科学知识的最新水平,同时尽量减少实验动物使用的方法,并考虑到自1989年以来一直在讨论的欧洲新指南提案。3. 尽管时间不允许对所有研究设计进行详细讨论,但已提出了几种被认为可为新治疗候选药物的生殖和发育毒性提供可接受测试的方法,以供进一步讨论。这些方法包括在有迹象表明潜在危害较低的情况下,大幅缩短研究的持续时间和规模,以及减少所用动物的数量。4. 无论最终在上市前评估中使用哪种组合,最重要的是研究人员详细说明所进行研究选择的基本原理。这应考虑到药物分子的具体特性及其拟议的临床用途。5. 本文反映了研讨会上进行的讨论,与会者已同意发表此文。其目的是将其用作讨论药品生殖和发育毒性测试统一方法的基础。因此,它将提供给监管机构、行业协会和其他相关团体,供其考虑、接受、修改或进行科学补充。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验